Pravastatin therapy and the risk of stroke
Meilof, J.F.; Uitdehaag, B.M.
New England Journal of Medicine 343(25): 1895; Author Reply 1895-1896
2000
ISSN/ISBN: 0028-4793 PMID: 11117989 Document Number: 518627
Document emailed within 1 workday
Related Documents
Crepaldi, G.; Baggio, G.; Arca, M.; Avellone, G.; Avogaro, P.; Bittolo Bon, G.; Bompiani, G.D.; Capurso, A.; Cattin, L.; D'Alŏ, G. 1991: Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I Archives of Internal Medicine 151(1): 146-152Hanchaiphiboolkul, S.; Poungvarin, N.; Nidhinandana, S.; Suwanwela, N.C.; Puthkhao, P.; Towanabut, S.; Tantirittisak, T.; Suwantamee, J.; Samsen, M. 2011: Prevalence of stroke and stroke risk factors in Thailand: Thai Epidemiologic Stroke (TES) Study Journal of the Medical Association of Thailand 94(4): 427-436
Woloszynska, I.; Stfpien, A. 2017: Risk Factors of Rt-Pa Therapy in Patients with Ischemic Stroke Acta Poloniae Pharmaceutica 74(1): 293-298
Mattle, H.P. 2004: Clopidogrel as basic therapy in high-risk stroke patients Praxis 93(34): 1364
Anagnostopoulos, G.K.; Tsiakos, S.; Margantinis, G.; Kostopoulos, P.; Arvanitidis, D. 2003: Acute pancreatitis due to pravastatin therapy Jop: Journal of the Pancreas 4(3): 129-132
Porela, P.; Kantola, I. 2002: Hypothyroidism, pravastatin therapy and myopathy Duodecim; Laaketieteellinen Aikakauskirja 118(7): 689-690
Zarranz Imirizaldu, J.J. 1997: Anti-aggregation therapy for prevention of cerebral ischemic stroke: a risk benefit analysis Medicina Clinica 109(20): 802-807
Laupacis, A.; Singer, D.; Jacobsen, A.; Dunn, M.; Dalen, J.; Albers, G. 1999: Risk factors for stroke and primary prevention of stroke in atrial fibrillation Journal of Thrombosis and Thrombolysis 7(1): 21-26
Pipatvanichgul, B.; Hanchaiphiboolkul, S.; Puthkhao, P.; Tantirittisak, T.; Towanabut, S. 2015: Association between Socioeconomic Status and Major Risk Factors of Stroke: Thai Epidemiologic Stroke (TES) Study Journal of the Medical Association of Thailand 98(8): 739-747
Adams, H.P.; Brott, T.G.; Furlan, A.J.; Gomez, C.R.; Grotta, J.; Helgason, C.M.; Kwiatkowski, T.; Lyden, P.D.; Marler, J.R.; Torner, J.; Feinberg, W.; Mayberg, M.; Thies, W. 1996: Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association Circulation 94(5): 1167-1174
Stoopler, E.T. 2010: A response to "Dental implications of acute stroke therapy and anticoagulation for stroke prevention" Compendium of Continuing Education in Dentistry 31(5): 322
Kirshner, H.S. 1996: Medical revolution: the prevention and treatment of stroke, 1996. Part 2. Medical prevention of stroke and acute stroke therapy Tennessee Medicine: Journal of the Tennessee Medical Association 89(11): 410-412
Ditschuneit, H.H.; Dreyer, M.; Dammann, H.G.; Ditschuneit, H. 1991: Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study Medizinische Klinik 86(3): 142-148
Lim, S.; Mora-Pinzon, M.; Park, T.; Yoon, W.; Crisostomo, P.R.; Cho, J.S. 2019: Medical therapy does not confer stroke prevention for all patients: identification of high-risk patients with asymptomatic carotid stenosis is still needed International Angiology: a Journal of the International Union of Angiology 38(5): 372-380
Barnett, H.J.; Gent, M.; Sackett, D.L.; Taylor, D.W. 1980: Randomized trial of therapy with platelet antiaggregants for threatened stroke. 2: Observations on the pathogenesis and natural history of threatened stroke Canadian Medical Association Journal 122(5): 535-540
Suntayakorn, C.; Rojjanasrirat, W. 2013: Effects of an empowerment program on health behaviors and stroke risk reduction of at-risk group in Thai rural community Journal of the Medical Association of Thailand 96(9): 1229-1238
Koczorek, M. 2001: Is your patient at risk for stroke? Cutting the risk in half! MMW Fortschritte der Medizin 143(35-36): 4-8
Brainin, M. 1995: Antihypertensive therapy in stroke: acute therapy, primary and secondary prevention Acta Medica Austriaca 22(3): 54-57
Permsirivanich, W.; Tipchatyotin, S.; Wongchai, M.; Leelamanit, V.; Setthawatcharawanich, S.; Sathirapanya, P.; Phabphal, K.; Juntawises, U.; Boonmeeprakob, A. 2009: Comparing the effects of rehabilitation swallowing therapy vs. neuromuscular electrical stimulation therapy among stroke patients with persistent pharyngeal dysphagia: a randomized controlled study Journal of the Medical Association of Thailand 92(2): 259-265
Wester, P.O. 1980: Risk factors for stroke Scandinavian Journal of Rehabilitation Medicine. Suppl 7: 6-10